SCHEMBL7958616

SCHEMBL7958616

Cc1cccc(-c2noc(-c3ccccc3OCCN(C)C)n2)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 9/20 0.67
SMN1; SMN2 Q16637 8/20 0.67
RAB9A P51151 8/20 0.67
ALDH1A1 P00352 5/20 0.67
TP53 P04637 4/20 0.67
HSD17B10 Q99714 3/20 0.67
HPGD P15428 3/20 0.67
MEN1 O00255 1/20 0.67
NFKB1 P19838 1/20 0.67
NFKB2 Q00653 1/20 0.67
KMT2A Q03164 1/20 0.67
RELA Q04206 1/20 0.67
MAPT P10636 5/20 0.53
GAA P10253 1/20 0.53
HTR7 P34969 1/20 0.52
KDM4E B2RXH2 4/20 0.50
TSHR P16473 3/20 0.50
POLB P06746 2/20 0.49
LMNA P02545 2/20 0.49
TTR P02766 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7954876 0.91 SMN1; SMN2 (0.55) NPC1SMN1; SMN2RAB9AALDH1A1TP53
Irampanel SCHEMBL678128 0.88 HTR7 (0.63) NPC1SMN1; SMN2RAB9AALDH1A1TP53
SCHEMBL7955275 0.88 SMN1; SMN2 (0.55) NPC1SMN1; SMN2RAB9AALDH1A1TP53
SCHEMBL7961527 0.88 SMN1; SMN2 (0.55) NPC1SMN1; SMN2RAB9AALDH1A1TP53
SCHEMBL7958630 0.88 NPC1 (0.74) NPC1SMN1; SMN2RAB9AALDH1A1TP53
SCHEMBL7958390 0.87 TTR (0.55) NPC1SMN1; SMN2RAB9AALDH1A1TP53
Irampanel SCHEMBL6879876 0.87 HTR7 (0.62) NPC1SMN1; SMN2RAB9AALDH1A1TP53
SCHEMBL7956767 0.87 SMN1; SMN2 (0.51) NPC1SMN1; SMN2RAB9AALDH1A1TP53
SCHEMBL7954777 0.85 NPC1 (0.53) NPC1SMN1; SMN2RAB9AALDH1A1TP53
SCHEMBL7958842 0.85 NPC1 (0.56) NPC1SMN1; SMN2RAB9AALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6277872-B1 ANTIISCHEMIC AGENTS; BRAIN DISORDERS BOEHRINGER INGELHEIM KG (DE) 2001-08-21 US disclosed